Dr. Martens plc (LON: DOCS)
London
· Delayed Price · Currency is GBP · Price in GBX56.40
+2.30 (4.25%)
Nov 22, 2024, 4:35 PM BST
Dr. Martens Income Statement
Financials in millions GBP. Fiscal year is April - March.
Millions GBP. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Revenue | 877.1 | 877.1 | 1,000 | 908.3 | 773 | 672.2 | Upgrade
|
| Revenue Growth (YoY) | -12.32% | -12.32% | 10.13% | 17.50% | 15.00% | 47.93% | Upgrade
|
| Cost of Revenue | 301.9 | 301.9 | 382.2 | 329.5 | 302.5 | 270.7 | Upgrade
|
| Gross Profit | 575.2 | 575.2 | 618.1 | 578.8 | 470.5 | 401.5 | Upgrade
|
| Selling, General & Admin | 377.7 | 377.7 | 373.1 | 315.8 | 247.6 | 217 | Upgrade
|
| Other Operating Expenses | -1.2 | -1.2 | - | - | - | - | Upgrade
|
| Operating Expenses | 448.8 | 448.8 | 427.3 | 352.3 | 281.4 | 245.9 | Upgrade
|
| Operating Income | 126.4 | 126.4 | 190.8 | 226.5 | 189.1 | 155.6 | Upgrade
|
| Interest Expense | -32.2 | -32.2 | -18.7 | -15.5 | -41.6 | -41.5 | Upgrade
|
| Interest & Investment Income | 3 | 3 | 1.9 | 0.1 | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | -4.2 | -4.2 | -10.7 | 3.2 | 3.8 | -0.5 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | 0.4 | - | - | Upgrade
|
| EBT Excluding Unusual Items | 93 | 93 | 163.3 | 214.7 | 151.3 | 113.6 | Upgrade
|
| Asset Writedown | - | - | -3.9 | -0.4 | -1.1 | -0.6 | Upgrade
|
| Other Unusual Items | - | - | - | - | -80.5 | -12 | Upgrade
|
| Pretax Income | 93 | 93 | 159.4 | 214.3 | 69.7 | 101 | Upgrade
|
| Income Tax Expense | 23.8 | 23.8 | 30.5 | 33.1 | 35 | 26.2 | Upgrade
|
| Earnings From Continuing Operations | 69.2 | 69.2 | 128.9 | 181.2 | 34.7 | 74.8 | Upgrade
|
| Net Income | 69.2 | 69.2 | 128.9 | 181.2 | 34.7 | 74.8 | Upgrade
|
| Net Income to Common | 69.2 | 69.2 | 128.9 | 181.2 | 34.7 | 74.8 | Upgrade
|
| Net Income Growth | -46.31% | -46.31% | -28.86% | 422.19% | -53.61% | 334.88% | Upgrade
|
| Shares Outstanding (Basic) | 984 | 984 | 1,001 | 1,000 | 1,000 | 1,000 | Upgrade
|
| Shares Outstanding (Diluted) | 986 | 986 | 1,001 | 1,003 | 1,000 | 1,000 | Upgrade
|
| Shares Change (YoY) | -1.56% | -1.56% | -0.17% | 0.25% | 0.04% | -0.00% | Upgrade
|
| EPS (Basic) | 0.07 | 0.07 | 0.13 | 0.18 | 0.03 | 0.07 | Upgrade
|
| EPS (Diluted) | 0.07 | 0.07 | 0.13 | 0.18 | 0.03 | 0.07 | Upgrade
|
| EPS Growth | -45.67% | -45.67% | -28.82% | 421.61% | -53.61% | 334.91% | Upgrade
|
| Free Cash Flow | 149.7 | 149.7 | 33.1 | 168.9 | 148.5 | 107.9 | Upgrade
|
| Free Cash Flow Per Share | 0.15 | 0.15 | 0.03 | 0.17 | 0.15 | 0.11 | Upgrade
|
| Dividend Per Share | 0.025 | 0.025 | 0.058 | 0.055 | - | - | Upgrade
|
| Dividend Growth | -56.34% | -56.34% | 6.18% | - | - | - | Upgrade
|
| Gross Margin | 65.58% | 65.58% | 61.79% | 63.72% | 60.87% | 59.73% | Upgrade
|
| Operating Margin | 14.41% | 14.41% | 19.07% | 24.94% | 24.46% | 23.15% | Upgrade
|
| Profit Margin | 7.89% | 7.89% | 12.89% | 19.95% | 4.49% | 11.13% | Upgrade
|
| Free Cash Flow Margin | 17.07% | 17.07% | 3.31% | 18.60% | 19.21% | 16.05% | Upgrade
|
| EBITDA | 141.7 | 141.7 | 204.4 | 236 | 198.1 | 163.4 | Upgrade
|
| EBITDA Margin | 16.16% | 16.16% | 20.43% | 25.98% | 25.63% | 24.31% | Upgrade
|
| D&A For EBITDA | 15.3 | 15.3 | 13.6 | 9.5 | 9 | 7.8 | Upgrade
|
| EBIT | 126.4 | 126.4 | 190.8 | 226.5 | 189.1 | 155.6 | Upgrade
|
| EBIT Margin | 14.41% | 14.41% | 19.07% | 24.94% | 24.46% | 23.15% | Upgrade
|
| Effective Tax Rate | 25.59% | 25.59% | 19.13% | 15.45% | 50.22% | 25.94% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.